Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10098-10105
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10098
Table 1 Comparison of therapeutic effects between the two groups, n (%)
Group
n
Significantly effective
Effective
Ineffective
Total efficiency
Research4326 (60.47)14 (32.56)3 (6.98)40 (93.02)
Control4317 (39.53)16 (37.21)10 (23.26)33 (76.74)
χ24.441
P value0.035
Table 2 Comparison of periodontal status between the two groups before and after treatment (mean ± SD)
Group
n
PLI
MD (mm)
SBI
PPD (mm)
Before treatment
Research 427.88 ± 0.683.39 ± 0.396.45 ± 0.655.39 ± 0.63
Control 428.01 ± 0.733.45 ± 0.376.68 ± 0.615.54 ± 0.70
t0.9510.7971.8431.137
P value0.3440.4270.0680.258
After treatment
Research 424.71 ± 0.160.61 ± 0.090.96 ± 0.170.76 ± 0.26
Control 425.35 ± 0.240.93 ± 0.151.35 ± 0.301.04 ± 0.41
t15.84513.0648.0774.119
P value0.0000.0000.0000.000
Table 3 Comparison of inflammatory factors in gingival crevicular fluid between the two groups before and after treatment (mean ± SD)
Group
n
IL-1β (pg/mL)
IL-10 (ug/L)
Before treatment
Research42212.59 ± 19.452.83 ± 0.69
Control42209.01 ± 22.312.77 ± 0.72
t0.8640.430
P value0.3900.668
After treatment
Research42139.04 ± 15.547.98 ± 1.01
Control42156.35 ± 18.105.56 ± 0.96
t5.18212.403
P value0.0000.000
Table 4 Comparison of the incidence of complications between the two groups, n (%)
Group
n
Poor healing
Periodontal infection
Dental pulp infection
Total incidence rate
Research431 (2.33)1 (2.33)0 (0.00)2 (4.65)
Control433 (6.98)2 (4.65)3 (6.98)8 (18.60)
χ24.074
P value0.044